Recombinant adeno-associated virus (rAAV) vectors are attractive candidates for the treatment of inherited and acquired retinal disease. Although rAAV vectors are well characterized in rodent models, a prerequisite to their clinical application in human patients is the thorough evaluation of their efficacy and safety in intermediate animal models. In this study, we describe rAAV-2-mediated expression of GFP reporter gene in retinal cells following local vector delivery in dogs. Subretinal delivery of rAAV.CMV.GFP was performed unilaterally in eight normal dogs from 6 weeks of age. The area of retinal transduction was maximized by the optimization of surgical techniques for subretinal vector delivery by pars-plana vitrectomy and the use of fine-gauge subretinal cannulae to create multiple retinotomies. rAAV-2 vectors mediated efficient stable reporter gene expression in photoreceptors and retinal pigment epithelial cells. We found efficient transduction of cone photoreceptors in addition to rods in both the canine retina and after subretinal vector delivery in another intermediate animal model, the feline retina. GFP expression in dogs was confined to the area of the retinal bleb and was sustained in cells at this site for at least 18 months. Electroretinography demonstrated a modest reduction in global rod-mediated retinal function following subretinal delivery of rAAV.CMV.GFP. Three of the eight animals developed delayed-onset intraocular inflammation, in two cases associated with a serum antibody response to GFP protein. We conclude that rAAV-2 vectors mediate efficient sustained transgene expression in rod and cone photoreceptors following subretinal delivery in this intermediate animal model. The possibility of adverse effects including intraocular immune responses and reduced retinal function requires further investigation prior to clinical applications in patients.
Introduction
Disorders of the retina are the most common causes of blindness in developed countries. Retinal degenerations including retinitis pigmentosa are the most common causes of inherited visual loss. 1 The majority of these result from mutations in genes expressed in photoreceptor cells and are currently untreatable.
1 Diabetic retinopathy and age-related macular degeneration are the most common causes of visual loss in the working age population and in the elderly respectively. 2, 3 Current treatments for these conditions are of limited efficacy and associated with significant adverse effects. 4, 5 There is growing interest in the development of gene therapy for retinal disease since this technology offers the possible means to arrest inherited degenerations through gene replacement or gene-suppression strategies, as well as effective treatments for acquired retinal diseases through the local sustained delivery of therapeutic molecules. Recombinant adeno-associated virus (rAAV) vectors are particularly attractive vectors for retinal gene transfer because they mediate efficient sustained gene expression in photoreceptor cells and retinal pigment epithelial cells. 6 The pattern and kinetics of rAAV-mediated reporter gene expression in the retina have been extensively described in rodents. [7] [8] [9] Although rAAV vectors efficiently transduce rod photoreceptor cells, their ability to transduce cones has not been demonstrated. 10 There is mounting evidence for the potential therapeutic value of rAAV vectors for the effective treatment of rodent models of retinal disease including retinal degeneration 11 and neovascularization. [12] [13] [14] While these results support the future application of gene transfer techniques in clinical trials in human patients, significant differences between the rodent eye and the human eye present cause for concern. A prerequisite to the application of rAAV-mediated retinal gene transfer in human patients is a thorough and rigorous evaluation of the efficacy and potential toxicity of the vector in intermediate animal models.
We have chosen principally to use the canine eye for this purpose for a number of reasons. Its larger size facilitates a more relevant surgical approach to the delivery of vector suspension to the subretinal space. Whereas in mice the small size of the globe and relatively large lens mean that only a trans-scleral, trans-choroidal approach is feasible, the larger size of the canine eye enables the use of standard vitreoretinal microsurgical techniques and a pars-plana approach, which is the preferred technique in human patients. The mouse eye has a very few cone photoreceptors that are scattered across the retina, whereas the canine eye has a cone-rich visual streak that is more analogous to the human macula. The dog is more amenable to sophisticated assessments of visual function such as behavioural testing and its longevity enables the long-term evaluation of the effects of interventions.
This study was designed to evaluate the efficiency, cell specificity, time course, and potential toxicity of rAAV (serotype 2)-mediated retinal transduction in the normal dog and to optimize the surgical techniques for subretinal delivery of vector suspension in this model. There have been a very few reports of rAAV-mediated gene transfer in large animals, 10, [15] [16] [17] largely as a result of the substantial resources required for work of this nature. Experience of retinal gene transfer in large animals remains very limited when compared with rodent models, and further studies are required to support clinical applications in patients. In this paper, we describe our own experience of rAAV-mediated gene transfer in a large animal and report a number of important original findings. We describe the surgical delivery of vector suspension to the subretinal space of very young dogs and perform a detailed evaluation of AAV-mediated expression in a number of animals over an extended time course. We demonstrate conclusively for the first time that rAAV vectors are able to transduce cone photoreceptors and confirm this finding in a second large animal model. We report an inflammatory response that was observed clinically in a minority of animals and an effect of subretinal vector delivery on electroretinographic responses and discuss the relevance of these findings to the future application of rAAV-mediated retinal gene transfer in patients.
Methods
Vector construction, virus production and determination of titre rAAV (serotype 2) plasmids expressing green fluorescent protein (GFP) under the control of a cytomegalovirus (CMV) promoter (pHAV 5.5) were produced using the replicating amplicon system described previously 18 with a slight modification in the purification procedure; the CsCl gradient purification step was replaced with an iodoxianol gradient followed by a one-step affinity purification procedure on a Heparin column. 19 The titres of the purified viruses were determined by infectious unit assay on 293 cells and by dot blot for DNA particles. The titre of injected vector suspension was 5 Â 10 9 infectious U/ml; 2 Â 10 11 particles/ml.
Surgery and anaesthesia
All animals were treated in a humane manner and were managed in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research. Subretinal delivery of rAAV.CMV.GFP was performed unilaterally in eight normal dogs. Contralateral uninjected eyes were used as controls. Two animals were setter-beagle crosses aged 12 weeks and six animals were pure-bred beagles aged 6 weeks. The operated eye was pretreated with topical prednisolone acetate 1% (Predforte) four times daily for 3 days preoperatively. Pupillary dilatation was achieved with topical tropicamide 1% (Mydriacyl) and phenylephrine 2.5% 30 min preoperatively. Anaesthesia was induced and maintained by inhalation of isoflurane in oxygen. Animals were intubated and ventilated using intermittent positive pressure and neuromuscular blockade was produced by intravenous vecuronium (Norcuron; Organon) 0.05-0.1 mg/kg. Sterile surgical technique was used throughout the procedure. The eyelids and conjunctival sac were thoroughly cleaned with iodine solution and antibiotic prophylaxis provided using intravenous co-amoxiclav (Augmentin; SmithKline Beecham) 20 mg/kg at the start of surgery. The fundus was viewed by means of an operating microscope using a hand-held plano-concave contact lens with hydroxy-propyl-methyl-cellulose (HPMC) as a contact solution. A pars-plana approach was used in all cases; a temporal sclerotomy was created approximately 3.5 mm posterior to the corneoscleral limbus to accommodate a 33-gauge or 41-gauge subretinal cannula (MISS Ophthalmics, UK). In six animals, a nonvitrectomy approach was used. In two animals, a second sclerotomy was created for infusion of Hartman's solution (Baxter, Norfolk, UK) with 1:100 adrenaline and a core vitrectomy was performed. Since the relatively small palpebral aperture in these animals offers only limited access to the sclera, the use of coaxial illumination from the operating microscope was used in preference to a third scleral port for endoillumination. The vector suspension was drawn up through the subretinal cannula into a 1 ml syringe. The cannula was introduced through the scleral port, advanced through the vitreous cavity and used to create up to three retinotomies. Vector suspension was injected under manual control through the retinotomies into the subretinal space to raise retinal blebs. This procedure was repeated at up to three sites in areas of tapetal and nontapetal retina at the posterior pole around the optic disc. Total volumes of 200-400 ml-virus suspension were delivered. Retinal vessels remained well-perfused during and following the procedure. No attempt was made to close the retinotomies or to reattach the retina surgically. The sclerotomy ports were closed and subconjunctival injection of betamethasone was performed at the end of the procedure. Postoperative analgesia was provided for 24 h with buprenorphine (Vetergesic; Alstoe Ltd, UK) 0.01 mg/kg twice daily in addition to anti-inflammatory treatment with carprofen (Rimadyl; Pfizer Ltd, UK) 2 mg/kg twice daily for 7 days and 1 mg twice daily for a further 7 days. All animals routinely received topical prednisolone 1% and chloramphenicol 0.5% four times daily, and topical atropine 1% and ketorolac twice daily. The frequency of topical medication was gradually reduced and finally discontinued 6 weeks after the surgical procedure. Animals were examined clinically on the day following surgery and thereafter at weekly intervals. The anterior segment was examined for signs of intraocular inflammation, and intraocular pressure was estimated by digital tonometry. The fundus was examined by indirect ophthalmoscopy to confirm retinal re-attachment and to identify any signs of adverse effects.
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In order to determine the ability of rAAV vectors to transduce cone photoreceptors in a second large animal model, we performed subretinal injections of rAAV.CMV.GFP in normal adult cats. Two adult female cats (aged 8 months) were maintained under deep medetomidine-ketamine anaesthesia given intramuscularly with atropine. Pars-plana vitrectomy and subretinal delivery of vector suspension was performed using a technique similar to that described above. The animals were humanely killed 8 weeks postoperatively by intravenous injection of pentobarbitone. The globes were immediately immersion fixed in 4% paraformaldehyde in sodium cacodylate buffer (0.1 M; pH 7.4; Electron Microscopy Sciences, Fort Washington, PA, USA). After 1 h, the anterior segments were removed and the posterior segments fixed for a further 4 h.
In vivo fluorescence funduscopy
GFP reporter gene expression was determined by fluorescence funduscopy in vivo. Fundus fluorescence photography was performed at weekly intervals following vector delivery using a Kowa Genesis fundus camera (Keeler, UK) with appropriate excitation and emission filters. Images were digitalized and fundus montages created using Adobe Photoshop.
Electroretinography
The effect of local subretinal delivery of rAAV vectors on global retinal function in dogs was evaluated using fullfield flash photopic and scotopic electroretinography (ERG). ERGs were recorded in a standardized fashion up to 8 weeks after treatment by the same investigator (FCS). All animals were dark-adapted for 60 min. All procedures for recording were performed under dim red light. Animals were sedated by intramuscular injection of medetomidine 10 mg/kg and butorphanol 0.4 mg/kg. The pupils were dilated using topical phenylephrine 2.5% and tropicamide 1%. A single drop of 2% HPMC was placed on each cornea to maintain epithelial hydration. ERGs were recorded using a commercially available instrument (Toennies Multiliner Vision, Jaeger/ Toennies) after placing corneal contact lens electrodes (Type Henkes, Jaeger/Toennies) and midline subdermal reference and ground electrodes. Bandpass filter cutoff frequencies were 1 and 300 Hz for all measurements. Ganzfeld ERG responses were recorded simultaneously from the subretinally injected right retina and the uninjected left retina to control for interanimal and test-retest variance. Care was taken to ensure that electrode impedances were minimal (around 5 kO) and symmetrical between the two eyes. Single flash recordings were obtained at light intensities increasing from 0. . These intervals were chosen in order to minimize the dark-adapted flash effect. After ERG was completed the medetomidine was reversed using atipamezole 50 mg/kg. The data were analysed using the Toennies Multiliner Vision program. For each animal the b-wave amplitudes at 100 and 1000 mcd/m 2 were used for statistical analysis. The bwave values (a-wave trough to b-wave peak) of the treated right eyes were compared with those of the untreated left control eyes and the mean difference for all animals was calculated. The statistical significance of this difference was determined using a paired Student's ttest.
Serology
Antibody responses to viral capsid proteins and to GFP protein were determined by ELISA of serum samples taken preoperatively and 6 weeks postoperatively. A sandwich ELISA method was used. 96-well Immunosorb r plates (NUNC, UK) were coated overnight using 100 ml of either rAAV.CMV.GFP (5000 virus particles/ml) or eGFP (Clontech, UK) at 1 mg/ml in phosphatebuffered saline (PBS). Wells were then washed 3 times using 200 ml of PBS with 0.05% Tween 20. Nonspecific binding was blocked by incubation with 1% BSA/PBS for 1 h. After washing again, test serums were added to wells in duplicate, diluted 1:50 with 1% BSA in PBS with 0.05% Tween 20. Wells containing diluent alone were used as negative control. Serum samples from mice known to have elevated titres of anti-GFP antibodies or anti-rAAV antibodies were used as positive controls. Plates were incubated for 1.5 h at room temperature. Following washing, 100 ml of HRP-conjugated sheep anti-canine IgG (1:10 000, Sigma, UK) was added to wells and incubated for 1 h at room temperature. After thorough washing, 100 ml of TMB substrate (Pharmingen, UK) was added and incubated in the dark for 30 min. To stop the reaction 100 ml of 1N HCl was added directly to the wells without washing. Plates were read within 20 min at 490 nm on an Emax r plate reader (Molecular Devices, UK).
Histology
For histological assessment of reporter gene expression, five dogs were humanely killed by intravenous injection of pentobarbitone 6-8 weeks following vector delivery. In animals where signs of intraocular inflammation were clinically apparent, vitreous and aqueous samples were cultured to investigate the possibility of infective endophthalmitis. Following enucleation, a full-thickness incision was made at the limbus and globes were immersion-fixed in freshly prepared 4% paraformaldehyde in PBS for 1 h. The eyecup was divided from the anterior segment and fixed for a further 24 h. Tissue was cryoprotected by immersion in 20% sucrose in PBS for 2 h, embedded in optimal cutting temperature medium and frozen in isopentane on liquid nitrogen. Cryosections 20 mm thick were counterstained with propidium iodide and mounted in Aquamount (Dako) for examination by fluorescence microscopy. For histological analysis of canine retina by light microscopy, fixed specimens were processed through a series of graded alcohols and embedded in paraffin wax. Sections 6 mm thick were counterstained with haematoxylin and eosin, mounted and viewed by light microscopy.
In order to determine whether cone photoreceptors are transduced by rAAV, cryosections of canine retina following delivery of rAAV.CMV.GFP vector were stained to identify cone photoreceptors. Sections were incubated overnight at 41C with biotinylated peanut agglutinin (Vector Laboratories, Burlingame, CA, USA), a lectin that specifically binds to the glycocalix of cone photoreceptor cells, 20 at a concentration of 25 mg/ml in Tris-buffered saline with 0.1% (v/v) Tween 20 (TBS-T) and 0.3% (w/v) albumin. After three washes with TBS-T, rAAV-mediated transduction of rod and cone photoreceptors JWB Bainbridge et al the sections were incubated with Alexa594-conjugated streptavidin (Molecular Probes Europe, Leiden, The Netherlands) in TBS-T for 2 h at room temperature. The sections were washed twice with TBS-T and once with water before mounting in fluorescence mounting medium for examination by confocal microscopy. The transduction efficiency of cone photoreceptors was determined by counting the number of GFP-positive and -negative lectin-stained cells in eight randomly selected high-power fields (146 mm wide) of the transduced area. Immunohistochemical analysis of feline retinas was performed 8 weeks following vector delivery. The globes were immersion-fixed in 4% paraformaldehyde in sodium cacodylate buffer (0.1 M; pH 7.4; Electron Microscopy Sciences, Fort Washington, PA, USA). After 1 h, the anterior segments were removed and the posterior segments fixed for a further 4 h. Samples of retina from the region of interest were rinsed in PBS and orientated in 5% agarose (Sigma, St Louis, MO, USA) in PBS. Sections 100 mm thick were cut using a vibratome (Technical Products International, Polysciences, Warrington, PA, USA) and incubated in normal donkey serum (1:20; Jackson ImmunoResearch, West Grove, PA, USA) in PBS containing 0.5% bovine serum albumin (BSA; Fisher Scientific, Pittsburgh, PA, USA), 0.1% Triton X-100 (Boehringer Mannheim, Indianapolis, IN, USA) and 0.1% sodium azide (Sigma, St Louis, MO, USA) overnight at 41C on a rotator (PBS+BSA+triton+azide¼'PBTA'). After removal of blocking serum, primary labelling was performed using antiglial fibrillary acidic protein (GFAP; 1:500; DAKO, Carpinteria, CA, USA) and biotinylated peanut agglutinin (PNA; Vector Laboratories, CA, USA) or antimedium to long wavelength (M/L) cone opsin (1:2000; gift from Dr J Nathans). After overnight incubation at 41C on a rotator, sections were rinsed in PBTA and incubated again overnight at 41C with the secondary antibody. Donkey anti-rabbit antibodies were used against the primary antibodies, conjugated to Cy3 or AMCA and streptavidin conjugated to Cy3 used against the PNA (Jackson ImmunoResearch, West Grove, PA, USA). All secondary reagents were used at a dilution of 1:200 in PBTA. The sections were then rinsed, mounted in fluorescent mounting medium (DAKO) and viewed by confocal microscopy.
Results
Subretinal delivery of rAAV was performed unilaterally in eight normal dogs. Contralateral unoperated eyes were used as controls. Details of individual animals are summarized in Table 1 . Optimal retinal transduction was achieved by first performing a core vitrectomy before raising retinal blebs of vector suspension using a 41-gauge subretinal cannula to create multiple retinotomies. Total volumes of up to 400 ml of virus suspension were injected through up to three retinotomies in each case. Using this technique, it was possible to create blebs extending across the greater part of the posterior pole, involving up to an estimated 20-30% of the total retinal area. The surgical procedures were uncomplicated except for an inadvertent posterior retinal tear in one case. In all cases the retinal bleb flattened spontaneously within 24 h of the procedure and the retina remained attached for the duration of the study.
Fundus fluorescence photography
GFP expression was evident by fluorescence funduscopy in all cases. Expression was first observed at 2-4 weeks postoperatively, increasing in intensity until 6-8 weeks when the intensity of expression reached a stable maximum (Figure 1 ). The area of GFP fluorescence was well defined, confined clinically to the site of the original retinal bleb(s) and has been sustained for up to 18 months at the present time. The intensity of GFP expression was similar in areas of tapetal and nontapetal fundus. Small discrete areas of loss of the tapetal reflex were evident at retinotomy sites and GFP fluorescence at these sites was absent. No fluorescence was detected by funduscopy in unoperated eyes.
Histology
Fluorescence microscopy of cryosections from the area of the retinal bleb demonstrated efficient transduction of photoreceptor cells and retinal pigment epithelial (RPE) cells 6 weeks following subretinal vector delivery (Figure 2) . The transduction rate of rod photoreceptors in the area of the retinal bleb was approximately 35%. In the retinal pigment epithelium, efficient expression of GFP was evident as a confluent band in the area of the retinal bleb, consistent with a transduction rate of greater than GFP fluorescence was evident in cells of the ganglion cell Layer scattered across the posterior pole and in nerve fibres at the optic nerve head (Figure 3a and b) . GFP expression was also observed in cells of the iris and 
rAAV-mediated transduction of cone photoreceptors
In order to determine whether rAAV-CMV-GFP vector is able to transduce cone photoreceptors, sections of canine retina following subretinal vector delivery were stained to identify cones. Histochemical staining by peanut agglutinin resulted in bright staining of the glycocalyx of the inner and outer segments of the cone photoreceptors (Figure 4a) . A fainter, but clear staining was present around the cell body of the cone photoreceptors. The cell bodies of cones are located at the border between the outer nuclear layer and the inner segment area 21 confirming the specificity of our staining. Although most of the GFP-positive photoreceptors were rods, in a minority of cells GFP colocalized precisely with peanut agglutinin staining of cones. In these cells, the GFP was present in the cell bodies and the inner segments and was bordered by the peanut agglutinin staining of the plasma membrane. It is estimated that 5-10% of the cone photoreceptors expressed GFP.
In order to determine the ability of rAAV vectors to transduce cone photoreceptors in a second large animal model, we performed subretinal injections of rAAV.CMV.GFP in normal adult cats. Confocal microscopy of normal feline retina in the region of subretinal vector delivery demonstrated efficient GFP expression in photoreceptor cells. In a proportion of photoreceptors, GFP expression was found to colocalize with conespecific staining by peanut agglutinin (Figure 4b) . Furthermore, GFP expression was found to colocalize with immunostaining of cones by an anti-M/L cone opsin antibody (Figure 4c ).
ERG
The effect of local subretinal delivery of rAAV.CMV. GFP on global retinal function was evaluated in four animals by full-field flash ERG. ERG responses to a series of increasing stimulus intensities were elicited. In normal animals, increasing stimulus intensity results in responses of increasing amplitude and shortened latency of the ERG b-wave. In this study, normal patterns of responses to increasing stimuli, in terms of both the latency and amplitude of the b-wave were elicited in both eyes of all animals studied. A variable reduction in b-wave amplitude, however, was observed following local subretinal delivery of rAAV.CMV.GFP compared to untreated contralateral eyes (Figure 5a ). In order to summarize ERG responses in this group of animals, mean b-wave amplitudes were calculated for each of two stimulus intensities (100 and 1000 mcd/m 2 . The mean reduction in b-wave amplitude following subretinal vector delivery was 25% for 100 mcd/m 2 stimuli ( Figure  5b ) and 13% for 1000 mcd/m 2 stimuli (Figure 5c ). These rAAV-mediated transduction of rod and cone photoreceptors JWB Bainbridge et al differences were statistically significant with P-values of 0.07 and 0.007 respectively.
Intraocular inflammatory responses following rAAV vector delivery
Antibody responses to rAAV capsid proteins and to GFP protein were determined by sandwich ELISA on serum samples taken preoperatively and after 8 weeks following vector delivery (Table 1) . No significant serum antibody response to rAAV capsid proteins was detected following subretinal vector delivery in any animal. Significant antibody responses to GFP protein were detected in two animals following vector delivery (animals x5 and x8).
Three of the eight dogs in this study developed a delayed-onset intraocular inflammatory response 4-6 weeks following subretinal delivery of rAAV (Table 1) . These animals developed progressive conjunctival injection, anterior chamber activity (without hypopyon), posterior synechiae and vitreous haze. Microscopy of haematoxylin and eosin-stained sections demonstrated a diffuse, nongranulomatous chronic inflammatory cell infiltrate involving the retina with focal extensions into the choroid. There was perivascular inflammation along the course of the central retinal vessels and involvement of the fibroglial septae of the optic nerve. The extent of inflammatory changes was most marked at the area of subretinal vector delivery but was also evident to lesser degree in other parts of the retina. Retinal GFP expression was observed histologically in inflamed eyes, although the level of expression appeared lower than that in uninflamed eyes. Samples of aqueous and vitreous revealed no organisms on Gram-staining and no growth on culture. In two of the three animals that developed intraocular inflammation, there were significant levels of GFP-specific antibodies. Animals without clinical signs of intraocular inflammation did not develop significant serological responses to GFP protein. Treatment of the intraocular inflammation in one animal by systemic and intensive topical corticosteroids resulted in a dramatic clinical improvement over the course of a 2-week period with resolution of anterior chamber flare and vitreous haze. The remaining two animals were killed for analysis soon after the diagnosis of intraocular inflammation, and in these cases the effect of immunosuppressive therapy was not investigated.
Discussion
The results of this study demonstrate significant differences between the rodent eye and the canine eye with respect to rAAV-mediated retinal gene transfer and highlight the importance of extending the evaluation of such vectors from rodents to more clinically relevant animal models before embarking on applications in patients.
We chose to deliver the vector in animals as young as 6 weeks because in many inherited retinal disorders, progressive degeneration occurs at an early age and we anticipate that gene-replacement strategies are likely to be most effective when established at an early stage in the disease process. 9 Conventional vitreoretinal microsurgical techniques facilitated the effective delivery of vector suspension to the subretinal space in these young dogs. We found that subretinal vector delivery was possible using a nonvitrectomy trans-vitreal technique but that a limited pars-plana vitrectomy offered a greater degree of surgical control and facilitated the delivery of larger volumes of vector suspension. We found that manually controlled injection of vector suspension using a 41-gauge cannula through multiple retinotomies to create blebs that became confluent was more effective than a single bleb in achieving delivery to a large area of the retina.
The results of this study demonstrate that in dogs, reporter gene expression in photoreceptors and RPE cells does not extend significantly beyond the original area of vector delivery even in the long term. This finding is consistent with previous reports of subretinal vector delivery in large animals using both rAAV 10, 16 and lentiviral 22 systems and has important implications for clinical applications. Effective gene transfer to a given area of retina by subretinal delivery of this vector is likely to require surgical detachment of the entire area. The control of retinal transduction by surgical delivery, however, offers a valuable means to minimize adverse effects of gene transfer on nontarget retina.
Following subretinal delivery of rAAV.CMV.GFP in mice, transgene expression is restricted to cells of the outer retina and is not observed in cells of the inner retina or anterior segment. In contrast, in dogs we observed significant GFP expression in ganglion cells scattered across the posterior pole and in optic nerve fibres. GFP fluorescence was also observed in cells of the iris and ciliary epithelia, though not in the lens, cornea or trabecular meshwork. It is most likely that the difference in patterns of tissue transduction between mice and dogs is the result of refluxed vector suspension from the subretinal space into the vitreous cavity through the retinotomy in dogs. This effect appeared to be more marked following vitrectomy, possibly because of the tendency of an intact vitreous gel to restrict diffusion of vector suspension. Evidence of transduction of ganglion cells (though not anterior segment tissues) following intravitreal injection of rAAV vectors in dogs in a previous study supports the role of this mechanism. 15 In mice the small size of the globe means that a trans-scleral, transchoroidal approach is conventionally used for subretinal vector delivery. Since a retinotomy is not normally created, the passage of vector suspension from the subretinal space into the vitreous and anterior chamber does not tend to occur. Following subretinal delivery in primates, only rare GFP-positive ganglion cells, confined to the point of needle entry have been observed and none in the optic nerve or anterior segment. 10 For clinical applications in patients, however, the possibility of vector reflux into the vitreous cavity cannot be excluded, and for this reason the restriction of gene expression to target cells by means of tissue-specific promoters may be required to prevent adverse effects resulting from inappropriate expression of therapeutic genes in nontarget cells.
Following subretinal delivery in dogs, rAAV-2 vectors mediated efficient GFP expression in photoreceptors and in retinal pigment epithelial cells. Previous studies in primates have suggested that rAAV-mediated photoreceptor transduction is specific to rods. 10 In this study, we conclusively demonstrate for the first time that rAAV vectors are able to transduce cone photoreceptors in addition to rods, and we confirm this observation in a rAAV-mediated transduction of rod and cone photoreceptors JWB Bainbridge et al second cone-rich intermediate animal model, the feline retina. This finding is of clinical importance because a significant number of inherited retinal degenerations involve cone photoreceptor cells. 1 In areas of retinal transduction in the canine eye approximately 5-10% of the cone photoreceptors expressed GFP. This proportion is substantially smaller than that of rods expressing GFP in the same area and suggests that cone photoreceptor cells may be less efficiently transduced by rAAV than rods. Thus the apparent absence of rAAV-mediated cone transduction in rodents may be a result of a relative inefficiency of transduction by rAAV vectors as well as the difficulty in identifying transduced cone photoreceptor cells in a retina that is cone-poor. The ability of rAAV vectors to efficiently transduce cones significantly extends their range of potential applications to include cone-based retinal degenerations.
Clinical and histological evidence of an intraocular inflammatory response was observed in three of eight animals following subretinal delivery of rAAV.CMV.GFP. In our experience, marked inflammatory responses are not observed following subretinal delivery of this vector in mice. Neither was ocular inflammation observed following vector delivery in the two cats described in this study. Possible causes for the inflammation in the dogs include sterile inflammatory responses to the surgical procedure, subacute bacterial endophthalmitis and immune responses to the viral vector or to the expressed protein GFP. The histological appearances were consistent with a nonspecific inflammatory reaction to the surgical procedure or with an immune-mediated response. Dogs are particularly liable to develop aggressive inflammatory responses following intraocular surgery, often in association with a fibrinous anterior uveitis. This type of response, however, seems an unlikely explanation for the inflammation observed in this study as clinical signs of inflammation were not apparent until several weeks after vector delivery.
Many of the features of the inflammatory responses are consistent with an immune response to expressed GFP protein. The onset of clinical signs of inflammation coincided with the establishment of maximal GFP expression and the histological changes were more marked in areas of transduced retina than in retina elsewhere in the same eye. We detected significant serum antibody responses to GFP protein in two of the three animals that developed inflammatory responses and in none of the unaffected animals tested. A serum antibody response to GFP in a dog following subretinal delivery of rAAV.CMV.GFP has been previously described, 15 although this was not apparently associated with intraocular inflammation.
The intraocular inflammation is not likely to be the result of antibody responses to vector-specific proteins. AAV is of low immunogenicity and in previous studies, even where significant serum antibody responses to viral capsid proteins have been detected following subretinal delivery of rAAV.CMV.GFP in nonhuman primates 10 or intravitreal delivery in dogs, 15 there was no clinical or histological evidence of inflammatory response. In the present study, we detected no significant serum antibody response to capsid proteins, and the onset of inflammation was delayed until some 4-6 weeks following vector delivery. Subacute endophthalmitis was excluded on the basis of negative microbiological investigations and the atypical histological appearances. Intraocular inflammation in the animal treated with intensive topical and systemic steroids responded very favourably without concomitant antibiotic cover suggesting that the primary cause of the inflammation was not microbial.
The induction of an immune response directed against expressed GFP reporter gene is not directly relevant to clinical applications in which other, therapeutic proteins are expressed. The possibility that similar immune responses might be directed against such expressed therapeutic proteins, however, is an important concern and its significance is two-fold. Firstly, such a response may neutralize the therapeutic effect of the expressed protein and secondly, the induction of sustained intraocular inflammation might cause significant adverse effects resulting in visual loss. In the present study, the majority of animals tolerated efficient retinal GFP expression in the long term with no evidence of intraocular inflammation. The reason that only a minority of animals developed immune responses in this study is not clear. One may speculate that the intensity and duration of immune responses to an expressed protein might depend on individual predispositions, the degree of compromise of the blood-retinal barrier and the nature of the expressed protein, for example its similarity to endogenously expressed proteins. The favourable response to prompt immunosuppressive treatment in this study suggests that such inflammatory reactions might be effectively controlled in the clinical context. Our findings, however, highlight the possibility of transgeneinduced immune responses that should be carefully considered in future preclinical and clinical studies of retinal gene transfer.
ERG demonstrated a modest but statistically significant reduction in global retinal function following subretinal delivery of rAAV.CMV.GFP compared to contralateral uninjected eyes, even in the absence of clinical signs of intraocular inflammation. This finding contrasts with our own experience in mice where we have found no significant change in ERG responses following subretinal delivery of the same vector or following subretinal delivery of PBS (unpublished data). This difference is particularly unexpected since the proportion of retina detached and transduced in mice is substantially greater than in the dogs in this study. The reasons for this difference are not clear. One possibility is a true species-dependent difference in responses to subretinal vector delivery such that murine retina is in some way resistant to the adverse effects of short-term detachment on long-term retinal function. Alternatively, the recording apparatus may be insufficiently sensitive to detect modest differences in responses between the eyes of mice.
Few studies have evaluated the functional effects of rAAV vector delivery to the retina in normal animals. Our finding of attenuated retinal function following subretinal vector delivery in normal dogs contrasts with the results of similar work in nonhuman primates in which no electroretinographic evidence of toxicity was detected following subretinal delivery of rAAV.CMV.GFP. 10 Our data are consistent, however, with the attenuation of rod ERG responses following subretinal delivery of recombinant feline immunodeficiency virus (rFIV) vectors expressing beta-galactosidase in nonhuman primates. 22 The attenuation of retinal func- 23 and in patients. 24, 25 Whether subretinal delivery of a vector results in additional adverse effects will require evaluation in further studies. Modifications of the surgical techniques or the coadminstration of neuroprotective agents may protect the retina against detachment-induced functional attenuation. In diseased retina, the beneficial effect of the expressed therapeutic transgene may more than compensate for delivery-related adverse effects. In summary, we have identified a number of important differences with respect to retinal gene transfer in dogs and mice. In dogs, rAAV-mediated gene expression in photoreceptors and RPE cells does not extend beyond the original area of vector delivery. Significant expression can occur, however, in the inner retina, optic nerve and ciliary epithelium, presumably as a result of vector reflux through the retinotomy. Following vector delivery to a cone-rich area of the canine retina, we found that rAAV transduces cone photoreceptors in addition to rods and were able to confirm this observation in the feline retina. In this study, subretinal delivery of rAAV vector was associated with a variable reduction in global retinal function as assessed by ERG. Intraocular inflammation, possibly the result of an immune response to expressed GFP protein, was observed in a minority of animals but in the majority of cases rAAV-mediated expression was well tolerated over a long period.
